176 related articles for article (PubMed ID: 29736707)
1. Validation and Development of an Escherichia coli Riboflavin Pathway Phenotypic Screen Hit as a Small-Molecule Ligand of the Flavin Mononucleotide Riboswitch.
Balibar CJ; Villafania A; Barbieri CM; Murgolo N; Roemer T; Wang H; Howe JA
Methods Mol Biol; 2018; 1787():19-40. PubMed ID: 29736707
[TBL] [Abstract][Full Text] [Related]
2. Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
Wang H; Mann PA; Xiao L; Gill C; Galgoci AM; Howe JA; Villafania A; Barbieri CM; Malinverni JC; Sher X; Mayhood T; McCurry MD; Murgolo N; Flattery A; Mack M; Roemer T
Cell Chem Biol; 2017 May; 24(5):576-588.e6. PubMed ID: 28434876
[TBL] [Abstract][Full Text] [Related]
3. Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch.
Howe JA; Xiao L; Fischmann TO; Wang H; Tang H; Villafania A; Zhang R; Barbieri CM; Roemer T
RNA Biol; 2016 Oct; 13(10):946-954. PubMed ID: 27485612
[TBL] [Abstract][Full Text] [Related]
4. The ribB FMN riboswitch from Escherichia coli operates at the transcriptional and translational level and regulates riboflavin biosynthesis.
Pedrolli D; Langer S; Hobl B; Schwarz J; Hashimoto M; Mack M
FEBS J; 2015 Aug; 282(16):3230-42. PubMed ID: 25661987
[TBL] [Abstract][Full Text] [Related]
5. Selective small-molecule inhibition of an RNA structural element.
Howe JA; Wang H; Fischmann TO; Balibar CJ; Xiao L; Galgoci AM; Malinverni JC; Mayhood T; Villafania A; Nahvi A; Murgolo N; Barbieri CM; Mann PA; Carr D; Xia E; Zuck P; Riley D; Painter RE; Walker SS; Sherborne B; de Jesus R; Pan W; Plotkin MA; Wu J; Rindgen D; Cummings J; Garlisi CG; Zhang R; Sheth PR; Gill CJ; Tang H; Roemer T
Nature; 2015 Oct; 526(7575):672-7. PubMed ID: 26416753
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry.
Rizvi NF; Howe JA; Nahvi A; Klein DJ; Fischmann TO; Kim HY; McCoy MA; Walker SS; Hruza A; Richards MP; Chamberlin C; Saradjian P; Butko MT; Mercado G; Burchard J; Strickland C; Dandliker PJ; Smith GF; Nickbarg EB
ACS Chem Biol; 2018 Mar; 13(3):820-831. PubMed ID: 29412640
[TBL] [Abstract][Full Text] [Related]
7. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis.
Pedrolli DB; Matern A; Wang J; Ester M; Siedler K; Breaker R; Mack M
Nucleic Acids Res; 2012 Sep; 40(17):8662-73. PubMed ID: 22740651
[TBL] [Abstract][Full Text] [Related]
8. Bacterial flavin mononucleotide riboswitches as targets for flavin analogs.
Pedrolli DB; Mack M
Methods Mol Biol; 2014; 1103():165-76. PubMed ID: 24318894
[TBL] [Abstract][Full Text] [Related]
9. Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch.
Motika SE; Ulrich RJ; Geddes EJ; Lee HY; Lau GW; Hergenrother PJ
J Am Chem Soc; 2020 Jun; 142(24):10856-10862. PubMed ID: 32432858
[TBL] [Abstract][Full Text] [Related]
10. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression.
Lee ER; Blount KF; Breaker RR
RNA Biol; 2009; 6(2):187-94. PubMed ID: 19246992
[TBL] [Abstract][Full Text] [Related]
11. The physiological role of riboflavin transporter and involvement of FMN-riboswitch in its gene expression in Corynebacterium glutamicum.
Takemoto N; Tanaka Y; Inui M; Yukawa H
Appl Microbiol Biotechnol; 2014 May; 98(9):4159-68. PubMed ID: 24531272
[TBL] [Abstract][Full Text] [Related]
12. A dual control mechanism synchronizes riboflavin and sulphur metabolism in Bacillus subtilis.
Pedrolli DB; Kühm C; Sévin DC; Vockenhuber MP; Sauer U; Suess B; Mack M
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14054-9. PubMed ID: 26494285
[TBL] [Abstract][Full Text] [Related]
13. Direct evolution of riboflavin kinase significantly enhance flavin mononucleotide synthesis by design and optimization of flavin mononucleotide riboswitch.
Du Y; Zhang X; Zhang H; Zhu R; Zhao Z; Han J; Zhang D; Zhang X; Zhang X; Pan X; You J; Rao Z
Bioresour Technol; 2023 Aug; 381():128774. PubMed ID: 36822556
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the interactions of flavin mononucleotide (FMN) and riboflavin with FMN riboswitch: a molecular dynamics simulation study.
Wakchaure PD; Jana K; Ganguly B
J Biomol Struct Dyn; 2020 Aug; 38(13):3856-3866. PubMed ID: 31498025
[TBL] [Abstract][Full Text] [Related]
15. Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets.
Jaroensuk J; Chuaboon L; Kesornpun C; Chaiyen P
Arch Biochem Biophys; 2023 Oct; 748():109762. PubMed ID: 37739114
[TBL] [Abstract][Full Text] [Related]
16. Rare variants of the FMN riboswitch class in
Atilho RM; Perkins KR; Breaker RR
RNA; 2019 Jan; 25(1):23-34. PubMed ID: 30287481
[TBL] [Abstract][Full Text] [Related]
17. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection.
Mansjö M; Johansson J
RNA Biol; 2011; 8(4):674-80. PubMed ID: 21593602
[TBL] [Abstract][Full Text] [Related]
18. Extensive Identification of Bacterial Riboflavin Transporters and Their Distribution across Bacterial Species.
Gutiérrez-Preciado A; Torres AG; Merino E; Bonomi HR; Goldbaum FA; García-Angulo VA
PLoS One; 2015; 10(5):e0126124. PubMed ID: 25938806
[TBL] [Abstract][Full Text] [Related]
19. Two Are Better Than One: Dual Targeting of Riboswitches by Metabolite Analogs.
Krajewski SS; Ignatov D; Johansson J
Cell Chem Biol; 2017 May; 24(5):535-537. PubMed ID: 28525764
[TBL] [Abstract][Full Text] [Related]
20. Binding free-energy landscapes of small molecule binder and non-binder to FMN riboswitch: All-atom molecular dynamics.
Higo J; Bekker GJ; Kamiya N; Fukuda I; Fukunishi Y
Biophys Physicobiol; 2023; 20(4):e200047. PubMed ID: 38344029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
